<?xml version="1.0" encoding="UTF-8"?>
<root encoding="UTF-8">
  <record>
    <Possible_Vaccine_Adverse_Events>1p36 deletion syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>2-Hydroxyglutaric aciduria</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>5'nucleotidase increased</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Acoustic neuritis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Acquired C1 inhibitor deficiency</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Acquired epidermolysis bullosa</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Acquired epileptic aphasia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Acute cutaneous lupus erythematosus</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Acute disseminated encephalomyelitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Acute encephalitis with refractory, repetitive partial seizures</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Acute febrile neutrophilic dermatosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Acute flaccid myelitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Acute haemorrhagic leukoencephalitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Acute haemorrhagic oedema of infancy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Acute kidney injury</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Acute macular outer retinopathy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Acute motor axonal neuropathy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Acute motor-sensory axonal neuropathy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Acute myocardial infarction</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Acute respiratory distress syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Acute respiratory failure</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Addison's disease</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Administration site thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Administration site vasculitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Adrenal thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Adverse event following immunisation</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Ageusia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Agranulocytosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Air embolism</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Alanine aminotransferase abnormal</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Alanine aminotransferase increased</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Alcoholic seizure</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Allergic bronchopulmonary mycosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Allergic oedema</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Alloimmune hepatitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Alopecia areata</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Alpers disease</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Alveolar proteinosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Ammonia abnormal</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Ammonia increased</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Amniotic cavity infection</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Amygdalohippocampectomy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Amyloid arthropathy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Amyloidosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Amyloidosis senile</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Anaphylactic reaction</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Anaphylactic shock</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Anaphylactic transfusion reaction</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Anaphylactoid reaction</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Anaphylactoid shock</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Anaphylactoid syndrome of pregnancy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Angioedema</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Angiopathic neuropathy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Ankylosing spondylitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Anosmia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Antiacetylcholine receptor antibody positive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Anti-actin antibody positive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Anti-aquaporin-4 antibody positive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Anti-basal ganglia antibody positive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Anti-cyclic citrullinated peptide antibody positive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Anti-epithelial antibody positive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Anti-erythrocyte antibody positive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Anti-exosome complex antibody positive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Anti-GAD antibody negative</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Anti-GAD antibody positive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Anti-ganglioside antibody positive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Antigliadin antibody positive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Anti-glomerular basement membrane antibody positive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Anti-glomerular basement membrane disease</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Anti-glycyl-tRNA synthetase antibody positive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Anti-HLA antibody test positive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Anti-IA2 antibody positive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Anti-insulin antibody increased</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Anti-insulin antibody positive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Anti-insulin receptor antibody increased</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Anti-insulin receptor antibody positive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Anti-interferon antibody negative</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Anti-interferon antibody positive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Anti-islet cell antibody positive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Antimitochondrial antibody positive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Anti-muscle specific kinase antibody positive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Anti-myelin-associated glycoprotein antibodies positive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Anti-myelin-associated glycoprotein associated polyneuropathy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Antimyocardial antibody positive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Anti-neuronal antibody positive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Antineutrophil cytoplasmic antibody increased</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Antineutrophil cytoplasmic antibody positive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Anti-neutrophil cytoplasmic antibody positive vasculitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Anti-NMDA antibody positive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Antinuclear antibody increased</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Antinuclear antibody positive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Antiphospholipid antibodies positive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Antiphospholipid syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Anti-platelet antibody positive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Anti-prothrombin antibody positive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Antiribosomal P antibody positive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Anti-RNA polymerase III antibody positive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Anti-saccharomyces cerevisiae antibody test positive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Anti-sperm antibody positive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Anti-SRP antibody positive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Antisynthetase syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Anti-thyroid antibody positive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Anti-transglutaminase antibody increased</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Anti-VGCC antibody positive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Anti-VGKC antibody positive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Anti-vimentin antibody positive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Antiviral prophylaxis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Antiviral treatment</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Anti-zinc transporter 8 antibody positive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Aortic embolus</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Aortic thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Aortitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Aplasia pure red cell</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Aplastic anaemia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Application site thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Application site vasculitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Arrhythmia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Arterial bypass occlusion</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Arterial bypass thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Arterial thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Arteriovenous fistula thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Arteriovenous graft site stenosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Arteriovenous graft thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Arteritis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Arteritis coronary</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Arthralgia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Arthritis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Arthritis enteropathic</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Ascites</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Aseptic cavernous sinus thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Aspartate aminotransferase abnormal</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Aspartate aminotransferase increased</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Aspartate-glutamate-transporter deficiency</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>AST to platelet ratio index increased</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>AST/ALT ratio abnormal</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Asthma</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Asymptomatic COVID-19</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Ataxia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Atheroembolism</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Atonic seizures</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Atrial thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Atrophic thyroiditis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Atypical benign partial epilepsy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Atypical pneumonia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Aura</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Autoantibody positive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Autoimmune anaemia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Autoimmune aplastic anaemia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Autoimmune arthritis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Autoimmune blistering disease</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Autoimmune cholangitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Autoimmune colitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Autoimmune demyelinating disease</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Autoimmune dermatitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Autoimmune disorder</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Autoimmune encephalopathy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Autoimmune endocrine disorder</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Autoimmune enteropathy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Autoimmune eye disorder</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Autoimmune haemolytic anaemia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Autoimmune heparin-induced thrombocytopenia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Autoimmune hepatitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Autoimmune hyperlipidaemia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Autoimmune hypothyroidism</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Autoimmune inner ear disease</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Autoimmune lung disease</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Autoimmune lymphoproliferative syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Autoimmune myocarditis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Autoimmune myositis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Autoimmune nephritis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Autoimmune neuropathy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Autoimmune neutropenia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Autoimmune pancreatitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Autoimmune pancytopenia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Autoimmune pericarditis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Autoimmune retinopathy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Autoimmune thyroid disorder</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Autoimmune thyroiditis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Autoimmune uveitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Autoinflammation with infantile enterocolitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Autoinflammatory disease</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Automatism epileptic</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Autonomic nervous system imbalance</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Autonomic seizure</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Axial spondyloarthritis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Axillary vein thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Axonal and demyelinating polyneuropathy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Axonal neuropathy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Bacterascites</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Baltic myoclonic epilepsy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Band sensation</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Basedow's disease</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Basilar artery thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Basophilopenia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>B-cell aplasia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Behcet's syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Benign ethnic neutropenia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Benign familial neonatal convulsions</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Benign familial pemphigus</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Benign rolandic epilepsy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Beta-2 glycoprotein antibody positive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Bickerstaff's encephalitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Bile output abnormal</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Bile output decreased</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Biliary ascites</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Bilirubin conjugated abnormal</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Bilirubin conjugated increased</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Bilirubin urine present</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Biopsy liver abnormal</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Biotinidase deficiency</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Birdshot chorioretinopathy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Blood alkaline phosphatase abnormal</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Blood alkaline phosphatase increased</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Blood bilirubin abnormal</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Blood bilirubin increased</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Blood bilirubin unconjugated increased</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Blood cholinesterase abnormal</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Blood cholinesterase decreased</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Blood pressure decreased</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Blood pressure diastolic decreased</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Blood pressure systolic decreased</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Blue toe syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Brachiocephalic vein thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Brain stem embolism</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Brain stem thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Bromosulphthalein test abnormal</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Bronchial oedema</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Bronchitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Bronchitis mycoplasmal</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Bronchitis viral</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Bronchopulmonary aspergillosis allergic</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Bronchospasm</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Budd-Chiari syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Bulbar palsy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Butterfly rash</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>C1q nephropathy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Caesarean section</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Calcium embolism</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Capillaritis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Caplan's syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Cardiac amyloidosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Cardiac arrest</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Cardiac failure</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Cardiac failure acute</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Cardiac sarcoidosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Cardiac ventricular thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Cardiogenic shock</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Cardiolipin antibody positive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Cardiopulmonary failure</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Cardio-respiratory arrest</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Cardio-respiratory distress</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Cardiovascular insufficiency</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Carotid arterial embolus</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Carotid artery thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Cataplexy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Catheter site thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Catheter site vasculitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Cavernous sinus thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>CDKL5 deficiency disorder</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>CEC syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Cement embolism</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Central nervous system lupus</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Central nervous system vasculitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Cerebellar artery thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Cerebellar embolism</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Cerebral amyloid angiopathy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Cerebral arteritis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Cerebral artery embolism</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Cerebral artery thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Cerebral gas embolism</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Cerebral microembolism</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Cerebral septic infarct</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Cerebral thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Cerebral venous sinus thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Cerebral venous thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Cerebrospinal thrombotic tamponade</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Cerebrovascular accident</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Change in seizure presentation</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Chest discomfort</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Child-Pugh-Turcotte score abnormal</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Child-Pugh-Turcotte score increased</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Chillblains</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Choking</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Choking sensation</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Cholangitis sclerosing</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Chronic autoimmune glomerulonephritis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Chronic cutaneous lupus erythematosus</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Chronic fatigue syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Chronic gastritis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Chronic inflammatory demyelinating polyradiculoneuropathy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Chronic recurrent multifocal osteomyelitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Chronic respiratory failure</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Chronic spontaneous urticaria</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Circulatory collapse</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Circumoral oedema</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Circumoral swelling</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Clinically isolated syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Clonic convulsion</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Coeliac disease</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Cogan's syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Cold agglutinins positive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Cold type haemolytic anaemia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Colitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Colitis erosive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Colitis herpes</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Colitis microscopic</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Colitis ulcerative</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Collagen disorder</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Collagen-vascular disease</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Complement factor abnormal</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Complement factor C1 decreased</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Complement factor C2 decreased</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Complement factor C3 decreased</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Complement factor C4 decreased</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Complement factor decreased</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Computerised tomogram liver abnormal</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Concentric sclerosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Congenital anomaly</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Congenital bilateral perisylvian syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Congenital herpes simplex infection</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Congenital myasthenic syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Congenital varicella infection</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Congestive hepatopathy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Convulsion in childhood</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Convulsions local</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Convulsive threshold lowered</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Coombs positive haemolytic anaemia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Coronary artery disease</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Coronary artery embolism</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Coronary artery thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Coronary bypass thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Coronavirus infection</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Coronavirus test</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Coronavirus test negative</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Coronavirus test positive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Corpus callosotomy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Cough</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Cough variant asthma</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>COVID-19</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>COVID-19 immunisation</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>COVID-19 pneumonia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>COVID-19 prophylaxis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>COVID-19 treatment</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Cranial nerve disorder</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Cranial nerve palsies multiple</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Cranial nerve paralysis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>CREST syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Crohn's disease</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Cryofibrinogenaemia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Cryoglobulinaemia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>CSF oligoclonal band present</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>CSWS syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Cutaneous amyloidosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Cutaneous lupus erythematosus</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Cutaneous sarcoidosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Cutaneous vasculitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Cyanosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Cyclic neutropenia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Cystitis interstitial</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Cytokine release syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Cytokine storm</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>De novo purine synthesis inhibitors associated acute inflammatory syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Death neonatal</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Deep vein thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Deep vein thrombosis postoperative</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Deficiency of bile secretion</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Deja vu</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Demyelinating polyneuropathy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Demyelination</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Dermatitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Dermatitis bullous</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Dermatitis herpetiformis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Dermatomyositis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Device embolisation</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Device related thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Diabetes mellitus</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Diabetic ketoacidosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Diabetic mastopathy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Dialysis amyloidosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Dialysis membrane reaction</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Diastolic hypotension</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Diffuse vasculitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Digital pitting scar</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Disseminated intravascular coagulation</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Disseminated intravascular coagulation in newborn</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Disseminated neonatal herpes simplex</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Disseminated varicella</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Disseminated varicella zoster vaccine virus infection</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Disseminated varicella zoster virus infection</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>DNA antibody positive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Double cortex syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Double stranded DNA antibody positive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Dreamy state</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Dressler's syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Drop attacks</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Drug withdrawal convulsions</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Dyspnoea</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Early infantile epileptic encephalopathy with burst-suppression</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Eclampsia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Eczema herpeticum</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Embolia cutis medicamentosa</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Embolic cerebellar infarction</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Embolic cerebral infarction</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Embolic pneumonia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Embolic stroke</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Embolism</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Embolism arterial</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Embolism venous</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Encephalitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Encephalitis allergic</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Encephalitis autoimmune</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Encephalitis brain stem</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Encephalitis haemorrhagic</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Encephalitis periaxialis diffusa</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Encephalitis post immunisation</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Encephalomyelitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Encephalopathy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Endocrine disorder</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Endocrine ophthalmopathy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Endotracheal intubation</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Enteritis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Enteritis leukopenic</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Enterobacter pneumonia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Enterocolitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Enteropathic spondylitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Eosinopenia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Eosinophilic fasciitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Eosinophilic granulomatosis with polyangiitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Eosinophilic oesophagitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Epidermolysis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Epilepsy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Epilepsy surgery</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Epilepsy with myoclonic-atonic seizures</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Epileptic aura</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Epileptic psychosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Erythema</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Erythema induratum</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Erythema multiforme</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Erythema nodosum</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Evans syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Exanthema subitum</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Expanded disability status scale score decreased</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Expanded disability status scale score increased</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Exposure to communicable disease</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Exposure to SARS-CoV-2</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Eye oedema</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Eye pruritus</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Eye swelling</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Eyelid oedema</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Face oedema</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Facial paralysis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Facial paresis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Faciobrachial dystonic seizure</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Fat embolism</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Febrile convulsion</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Febrile infection-related epilepsy syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Febrile neutropenia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Felty's syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Femoral artery embolism</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Fibrillary glomerulonephritis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Fibromyalgia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Flushing</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Foaming at mouth</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Focal cortical resection</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Focal dyscognitive seizures</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Foetal distress syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Foetal placental thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Foetor hepaticus</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Foreign body embolism</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Frontal lobe epilepsy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Fulminant type 1 diabetes mellitus</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Galactose elimination capacity test abnormal</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Galactose elimination capacity test decreased</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Gamma-glutamyltransferase abnormal</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Gamma-glutamyltransferase increased</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Gastritis herpes</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Gastrointestinal amyloidosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Gelastic seizure</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Generalised onset non-motor seizure</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Generalised tonic-clonic seizure</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Genital herpes</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Genital herpes simplex</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Genital herpes zoster</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Giant cell arteritis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Glomerulonephritis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Glomerulonephritis membranoproliferative</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Glomerulonephritis membranous</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Glomerulonephritis rapidly progressive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Glossopharyngeal nerve paralysis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Glucose transporter type 1 deficiency syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Glutamate dehydrogenase increased</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Glycocholic acid increased</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>GM2 gangliosidosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Goodpasture's syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Graft thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Granulocytopenia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Granulocytopenia neonatal</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Granulomatosis with polyangiitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Granulomatous dermatitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Grey matter heterotopia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Guanase increased</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Guillain-Barre syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Haemolytic anaemia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Haemophagocytic lymphohistiocytosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Haemorrhage</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Haemorrhagic ascites</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Haemorrhagic disorder</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Haemorrhagic pneumonia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Haemorrhagic varicella syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Haemorrhagic vasculitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Hantavirus pulmonary infection</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Hashimoto's encephalopathy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Hashitoxicosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Hemimegalencephaly</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Henoch-Schonlein purpura</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Henoch-Schonlein purpura nephritis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Hepaplastin abnormal</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Hepaplastin decreased</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Heparin-induced thrombocytopenia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Hepatic amyloidosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Hepatic artery embolism</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Hepatic artery flow decreased</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Hepatic artery thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Hepatic enzyme abnormal</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Hepatic enzyme decreased</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Hepatic enzyme increased</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Hepatic fibrosis marker abnormal</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Hepatic fibrosis marker increased</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Hepatic function abnormal</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Hepatic hydrothorax</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Hepatic hypertrophy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Hepatic hypoperfusion</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Hepatic lymphocytic infiltration</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Hepatic mass</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Hepatic pain</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Hepatic sequestration</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Hepatic vascular resistance increased</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Hepatic vascular thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Hepatic vein embolism</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Hepatic vein thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Hepatic venous pressure gradient abnormal</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Hepatic venous pressure gradient increased</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Hepatitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Hepatobiliary scan abnormal</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Hepatomegaly</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Hepatosplenomegaly</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Hereditary angioedema with C1 esterase inhibitor deficiency</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Herpes dermatitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Herpes gestationis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Herpes oesophagitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Herpes ophthalmic</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Herpes pharyngitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Herpes sepsis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Herpes simplex</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Herpes simplex cervicitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Herpes simplex colitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Herpes simplex encephalitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Herpes simplex gastritis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Herpes simplex hepatitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Herpes simplex meningitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Herpes simplex meningoencephalitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Herpes simplex meningomyelitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Herpes simplex necrotising retinopathy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Herpes simplex oesophagitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Herpes simplex otitis externa</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Herpes simplex pharyngitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Herpes simplex pneumonia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Herpes simplex reactivation</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Herpes simplex sepsis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Herpes simplex viraemia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Herpes simplex virus conjunctivitis neonatal</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Herpes simplex visceral</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Herpes virus infection</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Herpes zoster</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Herpes zoster cutaneous disseminated</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Herpes zoster infection neurological</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Herpes zoster meningitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Herpes zoster meningoencephalitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Herpes zoster meningomyelitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Herpes zoster meningoradiculitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Herpes zoster necrotising retinopathy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Herpes zoster oticus</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Herpes zoster pharyngitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Herpes zoster reactivation</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Herpetic radiculopathy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Histone antibody positive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Hoigne's syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Human herpesvirus 6 encephalitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Human herpesvirus 6 infection</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Human herpesvirus 6 infection reactivation</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Human herpesvirus 7 infection</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Human herpesvirus 8 infection</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Hyperammonaemia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Hyperbilirubinaemia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Hypercholia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Hypergammaglobulinaemia benign monoclonal</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Hyperglycaemic seizure</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Hypersensitivity</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Hypersensitivity vasculitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Hyperthyroidism</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Hypertransaminasaemia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Hyperventilation</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Hypoalbuminaemia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Hypocalcaemic seizure</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Hypogammaglobulinaemia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Hypoglossal nerve paralysis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Hypoglossal nerve paresis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Hypoglycaemic seizure</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Hyponatraemic seizure</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Hypotension</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Hypotensive crisis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Hypothenar hammer syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Hypothyroidism</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Hypoxia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Idiopathic CD4 lymphocytopenia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Idiopathic generalised epilepsy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Idiopathic interstitial pneumonia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Idiopathic neutropenia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Idiopathic pulmonary fibrosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>IgA nephropathy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>IgM nephropathy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>IIIrd nerve paralysis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>IIIrd nerve paresis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Iliac artery embolism</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Immune thrombocytopenia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Immune-mediated adverse reaction</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Immune-mediated cholangitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Immune-mediated cholestasis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Immune-mediated cytopenia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Immune-mediated encephalitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Immune-mediated encephalopathy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Immune-mediated endocrinopathy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Immune-mediated enterocolitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Immune-mediated gastritis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Immune-mediated hepatic disorder</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Immune-mediated hepatitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Immune-mediated hyperthyroidism</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Immune-mediated hypothyroidism</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Immune-mediated myocarditis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Immune-mediated myositis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Immune-mediated nephritis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Immune-mediated neuropathy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Immune-mediated pancreatitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Immune-mediated pneumonitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Immune-mediated renal disorder</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Immune-mediated thyroiditis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Immune-mediated uveitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Immunoglobulin G4 related disease</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Immunoglobulins abnormal</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Implant site thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Inclusion body myositis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Infantile genetic agranulocytosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Infantile spasms</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Infected vasculitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Infective thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Inflammation</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Inflammatory bowel disease</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Infusion site thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Infusion site vasculitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Injection site thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Injection site urticaria</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Injection site vasculitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Instillation site thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Insulin autoimmune syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Interstitial granulomatous dermatitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Interstitial lung disease</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Intracardiac mass</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Intracardiac thrombus</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Intracranial pressure increased</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Intrapericardial thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Intrinsic factor antibody abnormal</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Intrinsic factor antibody positive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>IPEX syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Irregular breathing</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>IRVAN syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>IVth nerve paralysis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>IVth nerve paresis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>JC polyomavirus test positive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>JC virus CSF test positive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Jeavons syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Jugular vein embolism</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Jugular vein thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Juvenile idiopathic arthritis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Juvenile myoclonic epilepsy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Juvenile polymyositis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Juvenile psoriatic arthritis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Juvenile spondyloarthritis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Kaposi sarcoma inflammatory cytokine syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Kawasaki's disease</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Kayser-Fleischer ring</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Keratoderma blenorrhagica</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Ketosis-prone diabetes mellitus</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Kounis syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Lafora's myoclonic epilepsy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Lambl's excrescences</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Laryngeal dyspnoea</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Laryngeal oedema</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Laryngeal rheumatoid arthritis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Laryngospasm</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Laryngotracheal oedema</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Latent autoimmune diabetes in adults</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>LE cells present</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Lemierre syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Lennox-Gastaut syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Leucine aminopeptidase increased</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Leukoencephalomyelitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Leukoencephalopathy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Leukopenia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Leukopenia neonatal</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Lewis-Sumner syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Lhermitte's sign</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Lichen planopilaris</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Lichen planus</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Lichen sclerosus</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Limbic encephalitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Linear IgA disease</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Lip oedema</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Lip swelling</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Liver function test abnormal</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Liver function test decreased</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Liver function test increased</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Liver induration</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Liver injury</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Liver iron concentration abnormal</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Liver iron concentration increased</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Liver opacity</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Liver palpable</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Liver sarcoidosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Liver scan abnormal</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Liver tenderness</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Low birth weight baby</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Lower respiratory tract herpes infection</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Lower respiratory tract infection</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Lower respiratory tract infection viral</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Lung abscess</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Lupoid hepatic cirrhosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Lupus cystitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Lupus encephalitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Lupus endocarditis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Lupus enteritis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Lupus hepatitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Lupus myocarditis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Lupus myositis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Lupus nephritis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Lupus pancreatitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Lupus pleurisy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Lupus pneumonitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Lupus vasculitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Lupus-like syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Lymphocytic hypophysitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Lymphocytopenia neonatal</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Lymphopenia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>MAGIC syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Magnetic resonance imaging liver abnormal</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Magnetic resonance proton density fat fraction measurement</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Mahler sign</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Manufacturing laboratory analytical testing issue</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Manufacturing materials issue</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Manufacturing production issue</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Marburg's variant multiple sclerosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Marchiafava-Bignami disease</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Marine Lenhart syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Mastocytic enterocolitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Maternal exposure during pregnancy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Medical device site thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Medical device site vasculitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>MELAS syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Meningitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Meningitis aseptic</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Meningitis herpes</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Meningoencephalitis herpes simplex neonatal</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Meningoencephalitis herpetic</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Meningomyelitis herpes</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>MERS-CoV test</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>MERS-CoV test negative</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>MERS-CoV test positive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Mesangioproliferative glomerulonephritis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Mesenteric artery embolism</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Mesenteric artery thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Mesenteric vein thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Metapneumovirus infection</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Metastatic cutaneous Crohn's disease</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Metastatic pulmonary embolism</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Microangiopathy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Microembolism</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Microscopic polyangiitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Middle East respiratory syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Migraine-triggered seizure</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Miliary pneumonia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Miller Fisher syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Mitochondrial aspartate aminotransferase increased</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Mixed connective tissue disease</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Model for end stage liver disease score abnormal</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Model for end stage liver disease score increased</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Molar ratio of total branched-chain amino acid to tyrosine</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Molybdenum cofactor deficiency</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Monocytopenia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Mononeuritis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Mononeuropathy multiplex</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Morphoea</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Morvan syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Mouth swelling</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Moyamoya disease</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Multifocal motor neuropathy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Multiple organ dysfunction syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Multiple sclerosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Multiple sclerosis relapse</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Multiple sclerosis relapse prophylaxis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Multiple subpial transection</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Multisystem inflammatory syndrome in children</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Muscular sarcoidosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Myasthenia gravis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Myasthenia gravis crisis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Myasthenia gravis neonatal</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Myasthenic syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Myelitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Myelitis transverse</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Myocardial infarction</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Myocarditis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Myocarditis post infection</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Myoclonic epilepsy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Myoclonic epilepsy and ragged-red fibres</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Myokymia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Myositis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Narcolepsy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Nasal herpes</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Nasal obstruction</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Necrotising herpetic retinopathy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Neonatal Crohn's disease</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Neonatal epileptic seizure</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Neonatal lupus erythematosus</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Neonatal mucocutaneous herpes simplex</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Neonatal pneumonia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Neonatal seizure</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Nephritis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Nephrogenic systemic fibrosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Neuralgic amyotrophy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Neuritis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Neuritis cranial</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Neuromyelitis optica pseudo relapse</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Neuromyelitis optica spectrum disorder</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Neuromyotonia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Neuronal neuropathy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Neuropathy peripheral</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Neuropathy, ataxia, retinitis pigmentosa syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Neuropsychiatric lupus</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Neurosarcoidosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Neutropenia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Neutropenia neonatal</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Neutropenic colitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Neutropenic infection</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Neutropenic sepsis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Nodular rash</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Nodular vasculitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Noninfectious myelitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Noninfective encephalitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Noninfective encephalomyelitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Noninfective oophoritis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Obstetrical pulmonary embolism</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Occupational exposure to communicable disease</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Occupational exposure to SARS-CoV-2</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Ocular hyperaemia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Ocular myasthenia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Ocular pemphigoid</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Ocular sarcoidosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Ocular vasculitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Oculofacial paralysis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Oedema</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Oedema blister</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Oedema due to hepatic disease</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Oedema mouth</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Oesophageal achalasia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Ophthalmic artery thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Ophthalmic herpes simplex</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Ophthalmic herpes zoster</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Ophthalmic vein thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Optic neuritis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Optic neuropathy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Optic perineuritis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Oral herpes</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Oral lichen planus</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Oropharyngeal oedema</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Oropharyngeal spasm</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Oropharyngeal swelling</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Osmotic demyelination syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Ovarian vein thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Overlap syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Paediatric autoimmune neuropsychiatric disorders associated with streptococcal infection</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Paget-Schroetter syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Palindromic rheumatism</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Palisaded neutrophilic granulomatous dermatitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Palmoplantar keratoderma</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Palpable purpura</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Pancreatitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Panencephalitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Papillophlebitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Paracancerous pneumonia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Paradoxical embolism</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Parainfluenzae viral laryngotracheobronchitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Paraneoplastic dermatomyositis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Paraneoplastic pemphigus</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Paraneoplastic thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Paresis cranial nerve</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Parietal cell antibody positive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Paroxysmal nocturnal haemoglobinuria</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Partial seizures</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Partial seizures with secondary generalisation</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Patient isolation</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Pelvic venous thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Pemphigoid</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Pemphigus</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Penile vein thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Pericarditis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Pericarditis lupus</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Perihepatic discomfort</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Periorbital oedema</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Periorbital swelling</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Peripheral artery thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Peripheral embolism</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Peripheral ischaemia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Peripheral vein thrombus extension</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Periportal oedema</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Peritoneal fluid protein abnormal</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Peritoneal fluid protein decreased</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Peritoneal fluid protein increased</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Peritonitis lupus</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Pernicious anaemia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Petit mal epilepsy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Pharyngeal oedema</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Pharyngeal swelling</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Pityriasis lichenoides et varioliformis acuta</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Placenta praevia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Pleuroparenchymal fibroelastosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Pneumobilia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Pneumonia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Pneumonia adenoviral</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Pneumonia cytomegaloviral</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Pneumonia herpes viral</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Pneumonia influenzal</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Pneumonia measles</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Pneumonia mycoplasmal</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Pneumonia necrotising</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Pneumonia parainfluenzae viral</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Pneumonia respiratory syncytial viral</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Pneumonia viral</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>POEMS syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Polyarteritis nodosa</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Polyarthritis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Polychondritis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Polyglandular autoimmune syndrome type I</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Polyglandular autoimmune syndrome type II</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Polyglandular autoimmune syndrome type III</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Polyglandular disorder</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Polymicrogyria</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Polymyalgia rheumatica</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Polymyositis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Polyneuropathy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Polyneuropathy idiopathic progressive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Portal pyaemia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Portal vein embolism</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Portal vein flow decreased</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Portal vein pressure increased</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Portal vein thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Portosplenomesenteric venous thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Post procedural hypotension</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Post procedural pneumonia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Post procedural pulmonary embolism</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Post stroke epilepsy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Post stroke seizure</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Post thrombotic retinopathy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Post thrombotic syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Post viral fatigue syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Postictal headache</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Postictal paralysis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Postictal psychosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Postictal state</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Postoperative respiratory distress</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Postoperative respiratory failure</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Postoperative thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Postpartum thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Postpartum venous thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Postpericardiotomy syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Post-traumatic epilepsy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Postural orthostatic tachycardia syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Precerebral artery thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Pre-eclampsia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Preictal state</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Premature labour</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Premature menopause</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Primary amyloidosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Primary biliary cholangitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Primary progressive multiple sclerosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Procedural shock</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Proctitis herpes</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Proctitis ulcerative</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Product availability issue</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Product distribution issue</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Product supply issue</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Progressive facial hemiatrophy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Progressive multifocal leukoencephalopathy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Progressive multiple sclerosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Progressive relapsing multiple sclerosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Prosthetic cardiac valve thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Pruritus</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Pruritus allergic</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Pseudovasculitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Psoriasis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Psoriatic arthropathy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Pulmonary amyloidosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Pulmonary artery thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Pulmonary embolism</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Pulmonary fibrosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Pulmonary haemorrhage</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Pulmonary microemboli</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Pulmonary oil microembolism</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Pulmonary renal syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Pulmonary sarcoidosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Pulmonary sepsis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Pulmonary thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Pulmonary tumour thrombotic microangiopathy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Pulmonary vasculitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Pulmonary veno-occlusive disease</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Pulmonary venous thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Pyoderma gangrenosum</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Pyostomatitis vegetans</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Pyrexia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Quarantine</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Radiation leukopenia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Radiculitis brachial</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Radiologically isolated syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Rash</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Rash erythematous</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Rash pruritic</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Rasmussen encephalitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Raynaud's phenomenon</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Reactive capillary endothelial proliferation</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Relapsing multiple sclerosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Relapsing-remitting multiple sclerosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Renal amyloidosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Renal arteritis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Renal artery thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Renal embolism</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Renal failure</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Renal vascular thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Renal vasculitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Renal vein embolism</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Renal vein thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Respiratory arrest</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Respiratory disorder</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Respiratory distress</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Respiratory failure</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Respiratory paralysis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Respiratory syncytial virus bronchiolitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Respiratory syncytial virus bronchitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Retinal artery embolism</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Retinal artery occlusion</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Retinal artery thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Retinal vascular thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Retinal vasculitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Retinal vein occlusion</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Retinal vein thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Retinol binding protein decreased</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Retinopathy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Retrograde portal vein flow</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Retroperitoneal fibrosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Reversible airways obstruction</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Reynold's syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Rheumatic brain disease</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Rheumatic disorder</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Rheumatoid arthritis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Rheumatoid factor increased</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Rheumatoid factor positive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Rheumatoid factor quantitative increased</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Rheumatoid lung</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Rheumatoid neutrophilic dermatosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Rheumatoid nodule</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Rheumatoid nodule removal</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Rheumatoid scleritis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Rheumatoid vasculitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Saccadic eye movement</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>SAPHO syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Sarcoidosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>SARS-CoV-1 test</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>SARS-CoV-1 test negative</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>SARS-CoV-1 test positive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>SARS-CoV-2 antibody test</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>SARS-CoV-2 antibody test negative</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>SARS-CoV-2 antibody test positive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>SARS-CoV-2 carrier</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>SARS-CoV-2 sepsis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>SARS-CoV-2 test</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>SARS-CoV-2 test false negative</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>SARS-CoV-2 test false positive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>SARS-CoV-2 test negative</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>SARS-CoV-2 test positive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>SARS-CoV-2 viraemia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Satoyoshi syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Schizencephaly</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Scleritis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Sclerodactylia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Scleroderma</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Scleroderma associated digital ulcer</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Scleroderma renal crisis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Scleroderma-like reaction</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Secondary amyloidosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Secondary cerebellar degeneration</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Secondary progressive multiple sclerosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Segmented hyalinising vasculitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Seizure</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Seizure anoxic</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Seizure cluster</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Seizure like phenomena</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Seizure prophylaxis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Sensation of foreign body</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Septic embolus</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Septic pulmonary embolism</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Severe acute respiratory syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Severe myoclonic epilepsy of infancy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Shock</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Shock symptom</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Shrinking lung syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Shunt thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Silent thyroiditis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Simple partial seizures</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Sjogren's syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Skin swelling</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>SLE arthritis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Smooth muscle antibody positive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Sneezing</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Spinal artery embolism</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Spinal artery thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Splenic artery thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Splenic embolism</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Splenic thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Splenic vein thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Spondylitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Spondyloarthropathy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Spontaneous heparin-induced thrombocytopenia syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Status epilepticus</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Stevens-Johnson syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Stiff leg syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Stiff person syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Stillbirth</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Still's disease</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Stoma site thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Stoma site vasculitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Stress cardiomyopathy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Stridor</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Subacute cutaneous lupus erythematosus</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Subacute endocarditis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Subacute inflammatory demyelinating polyneuropathy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Subclavian artery embolism</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Subclavian artery thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Subclavian vein thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Sudden unexplained death in epilepsy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Superior sagittal sinus thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Susac's syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Suspected COVID-19</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Swelling</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Swelling face</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Swelling of eyelid</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Swollen tongue</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Sympathetic ophthalmia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Systemic lupus erythematosus</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Systemic lupus erythematosus disease activity index abnormal</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Systemic lupus erythematosus disease activity index decreased</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Systemic lupus erythematosus disease activity index increased</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Systemic lupus erythematosus rash</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Systemic scleroderma</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Systemic sclerosis pulmonary</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Tachycardia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Tachypnoea</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Takayasu's arteritis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Temporal lobe epilepsy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Terminal ileitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Testicular autoimmunity</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Throat tightness</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Thromboangiitis obliterans</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Thrombocytopenia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Thrombocytopenic purpura</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Thrombophlebitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Thrombophlebitis migrans</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Thrombophlebitis neonatal</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Thrombophlebitis septic</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Thrombophlebitis superficial</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Thromboplastin antibody positive</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Thrombosis corpora cavernosa</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Thrombosis in device</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Thrombosis mesenteric vessel</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Thrombotic cerebral infarction</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Thrombotic microangiopathy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Thrombotic stroke</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Thrombotic thrombocytopenic purpura</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Thyroid disorder</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Thyroid stimulating immunoglobulin increased</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Thyroiditis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Tongue amyloidosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Tongue biting</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Tongue oedema</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Tonic clonic movements</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Tonic convulsion</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Tonic posturing</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Topectomy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Total bile acids increased</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Toxic epidermal necrolysis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Toxic leukoencephalopathy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Toxic oil syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Tracheal obstruction</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Tracheal oedema</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Tracheobronchitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Tracheobronchitis mycoplasmal</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Tracheobronchitis viral</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Transaminases abnormal</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Transaminases increased</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Transfusion-related alloimmune neutropenia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Transient epileptic amnesia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Transverse sinus thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Trigeminal nerve paresis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Trigeminal neuralgia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Trigeminal palsy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Truncus coeliacus thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Tuberous sclerosis complex</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Tubulointerstitial nephritis and uveitis syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Tumefactive multiple sclerosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Tumour embolism</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Tumour thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Type 1 diabetes mellitus</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Type I hypersensitivity</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Type III immune complex mediated reaction</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Uhthoff's phenomenon</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Ulcerative keratitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Ultrasound liver abnormal</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Umbilical cord thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Uncinate fits</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Undifferentiated connective tissue disease</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Upper airway obstruction</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Urine bilirubin increased</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Urobilinogen urine decreased</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Urobilinogen urine increased</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Urticaria</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Urticaria papular</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Urticarial vasculitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Uterine rupture</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Uveitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Vaccination site thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Vaccination site vasculitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Vagus nerve paralysis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Varicella</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Varicella keratitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Varicella post vaccine</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Varicella zoster gastritis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Varicella zoster oesophagitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Varicella zoster pneumonia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Varicella zoster sepsis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Varicella zoster virus infection</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Vasa praevia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Vascular graft thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Vascular pseudoaneurysm thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Vascular purpura</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Vascular stent thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Vasculitic rash</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Vasculitic ulcer</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Vasculitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Vasculitis gastrointestinal</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Vasculitis necrotising</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Vena cava embolism</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Vena cava thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Venous intravasation</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Venous recanalisation</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Venous thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Venous thrombosis in pregnancy</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Venous thrombosis limb</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Venous thrombosis neonatal</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Vertebral artery thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Vessel puncture site thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Visceral venous thrombosis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>VIth nerve paralysis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>VIth nerve paresis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Vitiligo</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Vocal cord paralysis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Vocal cord paresis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Vogt-Koyanagi-Harada disease</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Warm type haemolytic anaemia</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Wheezing</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>White nipple sign</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>XIth nerve paralysis</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>X-ray hepatobiliary abnormal</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Young's syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Zika virus associated Guillain Barre syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report</Source_Title>
    <Source_Author>Worldwide Safety Pfizer</Source_Author>
    <Source_Date>2021-04-30</Source_Date>
    <Source_Additional_Information>Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization</Source_Additional_Information>
    <Source_URL>https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Adenopathy</Possible_Vaccine_Adverse_Events>
    <Source_Title>Neuritis and Multiple Neuritis Following Serum Therapy</Source_Title>
    <Source_Author>George Wilson, M.D. and Samuel B. Hadden, M.D.</Source_Author>
    <Source_Date>1932-01-09</Source_Date>
    <Source_Additional_Information>'JAMA's. 1932; 98(2), pages 123-125</Source_Additional_Information>
    <Source_URL>https://jamanetwork.com/journals/jama/article-abstract/1153665</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Anaphylaxis</Possible_Vaccine_Adverse_Events>
    <Source_Title>Neuritis and Multiple Neuritis Following Serum Therapy</Source_Title>
    <Source_Author>George Wilson, M.D. and Samuel B. Hadden, M.D.</Source_Author>
    <Source_Date>1932-01-09</Source_Date>
    <Source_Additional_Information>'JAMA's. 1932; 98(2), pages 123-125</Source_Additional_Information>
    <Source_URL>https://jamanetwork.com/journals/jama/article-abstract/1153665</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Arthralgia</Possible_Vaccine_Adverse_Events>
    <Source_Title>Neuritis and Multiple Neuritis Following Serum Therapy</Source_Title>
    <Source_Author>George Wilson, M.D. and Samuel B. Hadden, M.D.</Source_Author>
    <Source_Date>1932-01-09</Source_Date>
    <Source_Additional_Information>'JAMA's. 1932; 98(2), pages 123-125</Source_Additional_Information>
    <Source_URL>https://jamanetwork.com/journals/jama/article-abstract/1153665</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Cardiac collapse</Possible_Vaccine_Adverse_Events>
    <Source_Title>Neuritis and Multiple Neuritis Following Serum Therapy</Source_Title>
    <Source_Author>George Wilson, M.D. and Samuel B. Hadden, M.D.</Source_Author>
    <Source_Date>1932-01-09</Source_Date>
    <Source_Additional_Information>'JAMA's. 1932; 98(2), pages 123-125</Source_Additional_Information>
    <Source_URL>https://jamanetwork.com/journals/jama/article-abstract/1153665</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Coma</Possible_Vaccine_Adverse_Events>
    <Source_Title>Neuritis and Multiple Neuritis Following Serum Therapy</Source_Title>
    <Source_Author>George Wilson, M.D. and Samuel B. Hadden, M.D.</Source_Author>
    <Source_Date>1932-01-09</Source_Date>
    <Source_Additional_Information>'JAMA's. 1932; 98(2), pages 123-125</Source_Additional_Information>
    <Source_URL>https://jamanetwork.com/journals/jama/article-abstract/1153665</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Death</Possible_Vaccine_Adverse_Events>
    <Source_Title>Neuritis and Multiple Neuritis Following Serum Therapy</Source_Title>
    <Source_Author>George Wilson, M.D. and Samuel B. Hadden, M.D.</Source_Author>
    <Source_Date>1932-01-09</Source_Date>
    <Source_Additional_Information>'JAMA's. 1932; 98(2), pages 123-125</Source_Additional_Information>
    <Source_URL>https://jamanetwork.com/journals/jama/article-abstract/1153665</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Encephalitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>Neuritis and Multiple Neuritis Following Serum Therapy</Source_Title>
    <Source_Author>George Wilson, M.D. and Samuel B. Hadden, M.D.</Source_Author>
    <Source_Date>1932-01-09</Source_Date>
    <Source_Additional_Information>'JAMA's. 1932; 98(2), pages 123-125</Source_Additional_Information>
    <Source_URL>https://jamanetwork.com/journals/jama/article-abstract/1153665</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Multiple neuritis</Possible_Vaccine_Adverse_Events>
    <Source_Title>Neuritis and Multiple Neuritis Following Serum Therapy</Source_Title>
    <Source_Author>George Wilson, M.D. and Samuel B. Hadden, M.D.</Source_Author>
    <Source_Date>1932-01-09</Source_Date>
    <Source_Additional_Information>'JAMA's. 1932; 98(2), pages 123-125</Source_Additional_Information>
    <Source_URL>https://jamanetwork.com/journals/jama/article-abstract/1153665</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Myelitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>Neuritis and Multiple Neuritis Following Serum Therapy</Source_Title>
    <Source_Author>George Wilson, M.D. and Samuel B. Hadden, M.D.</Source_Author>
    <Source_Date>1932-01-09</Source_Date>
    <Source_Additional_Information>'JAMA's. 1932; 98(2), pages 123-125</Source_Additional_Information>
    <Source_URL>https://jamanetwork.com/journals/jama/article-abstract/1153665</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Paralysis of the serratus magnus and other muscles</Possible_Vaccine_Adverse_Events>
    <Source_Title>Neuritis and Multiple Neuritis Following Serum Therapy</Source_Title>
    <Source_Author>George Wilson, M.D. and Samuel B. Hadden, M.D.</Source_Author>
    <Source_Date>1932-01-09</Source_Date>
    <Source_Additional_Information>'JAMA's. 1932; 98(2), pages 123-125</Source_Additional_Information>
    <Source_URL>https://jamanetwork.com/journals/jama/article-abstract/1153665</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Urticaria</Possible_Vaccine_Adverse_Events>
    <Source_Title>Neuritis and Multiple Neuritis Following Serum Therapy</Source_Title>
    <Source_Author>George Wilson, M.D. and Samuel B. Hadden, M.D.</Source_Author>
    <Source_Date>1932-01-09</Source_Date>
    <Source_Additional_Information>'JAMA's. 1932; 98(2), pages 123-125</Source_Additional_Information>
    <Source_URL>https://jamanetwork.com/journals/jama/article-abstract/1153665</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Acute disseminated encephalomyelitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation</Source_Title>
    <Source_Author>Steve Anderson, PhD, MPP</Source_Author>
    <Source_Date>2020-10-22</Source_Date>
    <Source_Additional_Information>page 17; Document was Recovered with the Internet Archive: Wayback Machine</Source_Additional_Information>
    <Source_URL>https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Acute myocardial infarction</Possible_Vaccine_Adverse_Events>
    <Source_Title>US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation</Source_Title>
    <Source_Author>Steve Anderson, PhD, MPP</Source_Author>
    <Source_Date>2020-10-22</Source_Date>
    <Source_Additional_Information>page 17; Document was Recovered with the Internet Archive: Wayback Machine</Source_Additional_Information>
    <Source_URL>https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Anaphylaxis</Possible_Vaccine_Adverse_Events>
    <Source_Title>US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation</Source_Title>
    <Source_Author>Steve Anderson, PhD, MPP</Source_Author>
    <Source_Date>2020-10-22</Source_Date>
    <Source_Additional_Information>page 17; Document was Recovered with the Internet Archive: Wayback Machine</Source_Additional_Information>
    <Source_URL>https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Arthritis and arthralgia/joint pain</Possible_Vaccine_Adverse_Events>
    <Source_Title>US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation</Source_Title>
    <Source_Author>Steve Anderson, PhD, MPP</Source_Author>
    <Source_Date>2020-10-22</Source_Date>
    <Source_Additional_Information>page 17; Document was Recovered with the Internet Archive: Wayback Machine</Source_Additional_Information>
    <Source_URL>https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Autoimmune disease</Possible_Vaccine_Adverse_Events>
    <Source_Title>US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation</Source_Title>
    <Source_Author>Steve Anderson, PhD, MPP</Source_Author>
    <Source_Date>2020-10-22</Source_Date>
    <Source_Additional_Information>page 17; Document was Recovered with the Internet Archive: Wayback Machine</Source_Additional_Information>
    <Source_URL>https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Convulsions/seizures</Possible_Vaccine_Adverse_Events>
    <Source_Title>US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation</Source_Title>
    <Source_Author>Steve Anderson, PhD, MPP</Source_Author>
    <Source_Date>2020-10-22</Source_Date>
    <Source_Additional_Information>page 17; Document was Recovered with the Internet Archive: Wayback Machine</Source_Additional_Information>
    <Source_URL>https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Deaths</Possible_Vaccine_Adverse_Events>
    <Source_Title>US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation</Source_Title>
    <Source_Author>Steve Anderson, PhD, MPP</Source_Author>
    <Source_Date>2020-10-22</Source_Date>
    <Source_Additional_Information>page 17; Document was Recovered with the Internet Archive: Wayback Machine</Source_Additional_Information>
    <Source_URL>https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Disseminated intravascular coagulation</Possible_Vaccine_Adverse_Events>
    <Source_Title>US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation</Source_Title>
    <Source_Author>Steve Anderson, PhD, MPP</Source_Author>
    <Source_Date>2020-10-22</Source_Date>
    <Source_Additional_Information>page 17; Document was Recovered with the Internet Archive: Wayback Machine</Source_Additional_Information>
    <Source_URL>https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Encephalitis/myelitis/encephalomyelitis/meningoencephalitis/meningitis/encepholapathy</Possible_Vaccine_Adverse_Events>
    <Source_Title>US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation</Source_Title>
    <Source_Author>Steve Anderson, PhD, MPP</Source_Author>
    <Source_Date>2020-10-22</Source_Date>
    <Source_Additional_Information>page 17; Document was Recovered with the Internet Archive: Wayback Machine</Source_Additional_Information>
    <Source_URL>https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Guillain-Barré syndrome</Possible_Vaccine_Adverse_Events>
    <Source_Title>US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation</Source_Title>
    <Source_Author>Steve Anderson, PhD, MPP</Source_Author>
    <Source_Date>2020-10-22</Source_Date>
    <Source_Additional_Information>page 17; Document was Recovered with the Internet Archive: Wayback Machine</Source_Additional_Information>
    <Source_URL>https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Kawasaki disease</Possible_Vaccine_Adverse_Events>
    <Source_Title>US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation</Source_Title>
    <Source_Author>Steve Anderson, PhD, MPP</Source_Author>
    <Source_Date>2020-10-22</Source_Date>
    <Source_Additional_Information>page 17; Document was Recovered with the Internet Archive: Wayback Machine</Source_Additional_Information>
    <Source_URL>https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Multisystem Inflammatory Syndrome in Children</Possible_Vaccine_Adverse_Events>
    <Source_Title>US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation</Source_Title>
    <Source_Author>Steve Anderson, PhD, MPP</Source_Author>
    <Source_Date>2020-10-22</Source_Date>
    <Source_Additional_Information>page 17; Document was Recovered with the Internet Archive: Wayback Machine</Source_Additional_Information>
    <Source_URL>https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Myocarditis/pericarditis</Possible_Vaccine_Adverse_Events>
    <Source_Title>US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation</Source_Title>
    <Source_Author>Steve Anderson, PhD, MPP</Source_Author>
    <Source_Date>2020-10-22</Source_Date>
    <Source_Additional_Information>page 17; Document was Recovered with the Internet Archive: Wayback Machine</Source_Additional_Information>
    <Source_URL>https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Narcolepsy and cataplexy</Possible_Vaccine_Adverse_Events>
    <Source_Title>US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation</Source_Title>
    <Source_Author>Steve Anderson, PhD, MPP</Source_Author>
    <Source_Date>2020-10-22</Source_Date>
    <Source_Additional_Information>page 17; Document was Recovered with the Internet Archive: Wayback Machine</Source_Additional_Information>
    <Source_URL>https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Non-anaphylactic allergic reactions</Possible_Vaccine_Adverse_Events>
    <Source_Title>US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation</Source_Title>
    <Source_Author>Steve Anderson, PhD, MPP</Source_Author>
    <Source_Date>2020-10-22</Source_Date>
    <Source_Additional_Information>page 17; Document was Recovered with the Internet Archive: Wayback Machine</Source_Additional_Information>
    <Source_URL>https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Other acute demyelinating diseases</Possible_Vaccine_Adverse_Events>
    <Source_Title>US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation</Source_Title>
    <Source_Author>Steve Anderson, PhD, MPP</Source_Author>
    <Source_Date>2020-10-22</Source_Date>
    <Source_Additional_Information>page 17; Document was Recovered with the Internet Archive: Wayback Machine</Source_Additional_Information>
    <Source_URL>https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Pregnancy and birth outcomes</Possible_Vaccine_Adverse_Events>
    <Source_Title>US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation</Source_Title>
    <Source_Author>Steve Anderson, PhD, MPP</Source_Author>
    <Source_Date>2020-10-22</Source_Date>
    <Source_Additional_Information>page 17; Document was Recovered with the Internet Archive: Wayback Machine</Source_Additional_Information>
    <Source_URL>https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Stroke</Possible_Vaccine_Adverse_Events>
    <Source_Title>US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation</Source_Title>
    <Source_Author>Steve Anderson, PhD, MPP</Source_Author>
    <Source_Date>2020-10-22</Source_Date>
    <Source_Additional_Information>page 17; Document was Recovered with the Internet Archive: Wayback Machine</Source_Additional_Information>
    <Source_URL>https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Thrombocytopenia</Possible_Vaccine_Adverse_Events>
    <Source_Title>US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation</Source_Title>
    <Source_Author>Steve Anderson, PhD, MPP</Source_Author>
    <Source_Date>2020-10-22</Source_Date>
    <Source_Additional_Information>page 17; Document was Recovered with the Internet Archive: Wayback Machine</Source_Additional_Information>
    <Source_URL>https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Transverse myelitis</Possible_Vaccine_Adverse_Events>
    <Source_Title>US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation</Source_Title>
    <Source_Author>Steve Anderson, PhD, MPP</Source_Author>
    <Source_Date>2020-10-22</Source_Date>
    <Source_Additional_Information>page 17; Document was Recovered with the Internet Archive: Wayback Machine</Source_Additional_Information>
    <Source_URL>https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Vaccine enhanced disease</Possible_Vaccine_Adverse_Events>
    <Source_Title>US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation</Source_Title>
    <Source_Author>Steve Anderson, PhD, MPP</Source_Author>
    <Source_Date>2020-10-22</Source_Date>
    <Source_Additional_Information>page 17; Document was Recovered with the Internet Archive: Wayback Machine</Source_Additional_Information>
    <Source_URL>https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download</Source_URL>
  </record>
  <record>
    <Possible_Vaccine_Adverse_Events>Venous thromboembolism</Possible_Vaccine_Adverse_Events>
    <Source_Title>US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation</Source_Title>
    <Source_Author>Steve Anderson, PhD, MPP</Source_Author>
    <Source_Date>2020-10-22</Source_Date>
    <Source_Additional_Information>page 17; Document was Recovered with the Internet Archive: Wayback Machine</Source_Additional_Information>
    <Source_URL>https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download</Source_URL>
  </record>
</root>
